NCT00597051View on ClinicalTrials.gov

Study of 3 Doses of ARD-0403 in Testosterone Deficient Men

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

February 28, 2006

Study Completion Date

February 28, 2006

Conditions
Hypogonadism
Interventions
DRUG

ARD-0403

Trial Locations (1)

220 007

Republican Endocrinology Center Hospital, Minsk

Sponsors
All Listed Sponsors
lead

Ardana Bioscience Ltd

INDUSTRY

NCT00597051 - Study of 3 Doses of ARD-0403 in Testosterone Deficient Men | Biotech Hunter | Biotech Hunter